Treatment of Refractory/Relapsed Non-Hodgkin Lymphoma With TriCAR-T_CD19
Clinical trial NCT03497533 · UNKNOWN
Trial details
- NCT number
- NCT03497533
- Sponsor
- Timmune Biotech Inc.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-03
- Primary completion
- 2020-12-31
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.